3,170
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Differential expression of miRNAs in a human developing neuronal cell line chronically infected with Zika virus

, , , &
Article: 1909902 | Received 09 Dec 2020, Accepted 25 Mar 2021, Published online: 14 Apr 2021

References

  • Dick GWA. Epidemiological notes on some viruses isolated in Uganda (Yellow Fever, Rift Valley Fever, Bwamba Fever, West Nile, Mengo, Semliki Forast, Bunyamwera, Ntaya, Uganda S and Zika Viruses). Trans R Soc Trop Med Hyg. 1953;47:13–8.
  • Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study. Lancet. 2016;387:2125–2132.
  • Dick GWA, Kitchen SF, Haddow AJ. Zika virus (I). Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46:509–534.
  • Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, federated states of micronesia. N Engl J Med. 2009;360:2536–2543.
  • Musso D, Nilles E, Cao-Lormeau V-M. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014;10:O595–O596.
  • De Oliveira KW, Cortez-Escalante J, Tgh DO, et al. Increase in reported prevalence of microcephaly in infants born to women living in areas with confirmed Zika virus transmission during the first trimester of pregnancy - Brazil, 2015. MMWR Morbidity Mortality Weekly Reports. 2016;65:242–247.
  • Bagasra O, Addanki KC, Hughes BW, et al. Cellular targets and receptor of sexual transmission of Zika virus. Appl Immunohistochem Mol Morphol. 2017;25(10):679–686..
  • Masmejan S, Musso D, Vouga M, et al. Zika Virus. Pathogens. 2020;9(11):898.
  • Sharma V, Sharma M, Dhull D, et al. Zika virus: an emerging challenge to public health worldwide. Can J Microbiol. 2020;66(2):87–98.
  • Silva NM, Santos NC, Martins IC. Dengue and Zika viruses: epidemiological history, potential therapies, and promising vaccines. Trop Med Infect Dis. 2020;5(4):E150.
  • Rodriguez-Barraquer I, Costa F, Nascimento EJM, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019;363:607–610.
  • Cohen J. Steep drop in Zika cases undermines vaccine trial. Science. 2018;361:6407.
  • McClean E, Bhattarai R, Hughes BW, et al. Computational identification of mutually homologous Zika virus miRNAs that target microcephaly genes. Libyan J Med. 2017;12:1304505.
  • Bagasra O, Prilliman KP. RNA Interference: the molecular immune system. J Mol Histol. 2004;35:545–553.
  • Bhattacharyya P, Biswas SC. Small non-coding RNAs: do they encode answers for controlling SARS-CoV-2 in the future? Front Microbiol. 2020;11:571553.
  • Wong RR, Abd-Aziz N, Affendi S, et al. Role of microRNAs in antiviral responses to dengue infection. J Biomed Sci. 2020;27(1):4.
  • Hughes BW, Addanki KC, Sriskanda A, et al. Infectivity of immature neurons to Zika virus: a link to congenital zika syndrome. EBioMedicine. 2016;10:66–70.
  • Reczko M, Maragkakis M, Alexiou P, et al. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28(6):771–776.
  • Tenoever BR. RNA viruses and the host microRNA machinery. Nature Rev Microbiol. 2013;11:169–180.
  • QIAGEN. QIAseq miRNA library kit handbook for illumina NGS systems. 2020 Jul. Available from: https://www.qiagen.com/us/resources/resourcedetail?id=f0b9d117-f8c6-4825-9069-3236ed65521d&lang=en
  • Ragan C, Zuker M, Ragan MA. Quantitative prediction of miRNA-mRNA interaction based on equilibrium concentrations. PLoS Compuational Biol. 2011;7(2):e1001090..
  • Valente AP, Moraes AH. Zika virus proteins at an atomic scale: how does structural biology help us to understand and develop vaccines and drugs against Zika virus infection? J Venom Animal Toxins Incl Trop Dis. 2019;25:e20190013.
  • Mahapatra S, Challagundla KB. Neuroblastoma. In: StatPearls Treasure Island (FL): State Pearls Publishing; 2020. PMID: 28846355.
  • Yang C, Gong R, De Val N. Development of neutralizing antibodies against Zika virus based on its envelope protein structure. Virol Sin. 2019;34(2):168–174.
  • Sotcheff S, Routh A. Understanding flavivirus capsid protein functions: the tip of the iceberg. Pathogens. 2020;9(1):42.
  • Oliveira ERA, Mohana-Borges R, De Alencastro RB, et al. The flavivirus capsid protein: structure, function, and perspectives towards drug design. Virus Res. 2017;227:115–123.
  • Sirohi D, Kuhn RJ. Zika virus structure, maturation, and receptors. J Infect Dis. 2017;216:S935–S944.
  • Hu Y, Sun L. Systematic analysis of structure similarity between Zika virus and other flaviviruses. ACS Infect Dis. 2019;5(7):1070–1080.
  • Zeng J, Dong S, Luo Z, et al. The Zika virus capsid disrupts corticogenesis by suppressing dicer activity and miRNA biogenesis. Cell Stem Cell. 2020;27(4):618–632.e9.
  • Pierson TC, Diamond MS. The continued threat of emerging flaviviruses. Nat Microbiol. 2020;5(6):796–812.
  • Tan MJM, Chan KWK, Ng IHW, et al. The potential role of the ZIKV NS5 nuclear spherical-shell structures in cell type-specific host immune modulation during ZIKV infection. Cells. 2019;8(12):1519.
  • Brown WC, Akey DL, Konwerski JR, et al. Extended surface for membrane association in Zika virus NS1 structure. Nat Struct Mol Biol. 2016;23(9):865–867.
  • Wang B, Thurmond S, Hai R, et al. Structure and function of Zika virus NS5 protein: perspectives for drug design. Cell Mol Life Sci. 2018;75(10):1723–1736.
  • Elshahawi H, Hassan SS, Balasubramaniam V. Importance of Zika virus NS5 protein for viral replication. Pathogens. 2019;8(4):169.